Mayr-Melnhof Karton (MMK) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
18 Sep, 2026Business overview and strategic positioning
Operates a diversified global packaging platform with three divisions: Board & Paper, Food & Premium Packaging, and Pharma & Healthcare Packaging, producing 3.1m tonnes of cartonboard, paper, and pulp annually and 3.1bn m² of packaging.
Maintains a well-invested, vertically integrated global footprint with 60 production facilities in 15 countries, serving over 3,500 customers in 130+ countries.
Holds leading market positions in Europe for folding cartons, premium packaging, and secondary pharma packaging, with 71% of sales from Food & Premium and 29% from Pharma & Healthcare.
Strong ESG credentials, including CDP AAA ratings and high renewable electricity sourcing, with circularity and sustainability embedded in the business model.
Strategic focus on plastic substitution, organic growth, operational excellence, and selective M&A to drive future value creation.
Financial performance and segment results
Achieved €3.8bn in sales and €421m like-for-like transactional EBITDA in 2025, with an 11% EBITDA margin.
Food & Premium Packaging generated €1,450m in revenues and €205m adjusted EBITDA (14% margin) in 2025, with strong regional and customer diversification.
Pharma & Healthcare Packaging delivered €618m in revenues and €78m adjusted EBITDA (13% margin) in 2025, with a comprehensive product offering and low customer concentration.
Board & Paper segment reported €1,930m in revenues and €115m adjusted EBITDA (6% margin) in 2025, with 3.1m tonnes produced and a focus on operational excellence.
Half-year 2026 results show sequential EBITDA improvement, with Pharma & Healthcare up 14%, Food & Premium up 1%, and Board & Paper down 19%; Fit-For-Future program raised its expected P&L contribution to over €330m by 2027.
Operational excellence and cost leadership
Maintains an advantageous cost position in Europe, with 80% of capacity in the lowest two quartiles of the cost curve, supported by asset optimization and vertical integration.
Capacity utilization improved to 87% in H1 2026, with regained operational excellence after major machine rebuilds and investments.
Deep vertical integration across the value chain, processing 2.1m tonnes of recycled and virgin fiber, and 86% internal pulp supply.
Supplier-of-choice status with a globally diverse blue-chip customer base, high supply security, and no major client dependencies.
Latest events from Mayr-Melnhof Karton
- Stable adjusted EBITDA and strong Pharma & Healthcare Packaging growth offset market headwinds.MMK
H1 2026 - Fit-For-Future programme drove resilient earnings and margin stability despite market softness.MMK
H1 2026 (Q&A) - Efficiency gains and transformation drive profit growth and resilience amid market challenges.MMK
Austrian Select Conference - Adjusted operating profit up 2.8%, sales down 4.8%, dividend up 11%, and cost savings delivered.MMK
H2 2025 - Adjusted operating profit up 15% like-for-like, with €250M+ in savings targeted by 2027.MMK
H2 2025 (Q&A) - Profits fell as lower prices and higher costs offset volume gains; recovery expected in 2025.MMK
Q3 2024 - Profitability and cash flow improved, but margins declined amid weak demand and lower prices.MMK
H1 2024 - Earnings rose sharply but free cash flow turned negative amid soft demand and overcapacity.MMK
Q1 2025 - EPS up, net debt down, but sales and margins fell amid weak demand and overcapacity.MMK
H2 2024